Atlantic Biologicals Corporation Enters into Deferred Prosecution Agreement in Opioid Distribution Scheme

Atlantic Biologicals Corporation, a Miami-based pharmaceutical wholesaler, has agreed to a two-year deferred prosecution agreement with the Justice Department related to an opioid distribution scheme. The agreement represents a settlement of allegations involving improper distribution practices in the opioid market.